Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Aldeyra Therapeutics, Inc.

NASDAQ: ALDX · Life Sciences · 4 alerts · CIK 1341235

Share price
$0.6696Close, Nov 16
Market cap
$40.4M
Shares outstanding
60.36MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Aldeyra Therapeutics, Inc. filings on SEC EDGAR ↗

7:01 AM ET 8-K
Investor Presentation

Aldeyra Therapeutics Investor Presentation

Aldeyra Therapeutics announced its intent to submit a Formal Dispute Resolution Request (FDRR) to the FDA appealing a prior Complete Response Letter for reproxalap in dry eye disease. The company also extended its projected cash runway into 2029 and filed a formal supplemental presentation detailing the regulatory update and upcoming meeting with the FDA's Office of New Drugs.

Counterparty
FDA

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.